Suppr超能文献

持续性隐匿性乙型肝炎病毒感染:实验结果与临床意义

Persistent occult hepatitis B virus infection: experimental findings and clinical implications.

作者信息

Mulrooney-Cousins Patricia M, Michalak Tomasz I

出版信息

World J Gastroenterol. 2007 Nov 21;13(43):5682-6. doi: 10.3748/wjg.v13.i43.5682.

Abstract

Hepatitis B virus (HBV) is a highly pathogenic virus that causes chronic liver diseases in millions of people globally. In addition to a symptomatic, serologically evident infection, occult persistent HBV carriage has been identified since nucleic acid amplification assays of enhanced sensitivity became introduced for detection of hepadnaviral genomes and their replicative intermediates. Current evidence indicates that occult HBV infection is a common and long-term consequence of resolution of acute hepatitis B. This form of residual infection is termed as secondary occult infection (SOI). The data from the woodchuck model of HBV infection indicate that exposure to small amounts of hepadnavirus can also cause primary occult infection (POI) where virus genome, but no serological makers of exposure to virus, are detectable, and the liver may not be involved. However, virus replicates at low levels in the lymphatic system in both these forms. We briefly summarize the current understanding of the nature and characteristics of occult hepadnaviral persistence as well as of its documented and expected pathological consequences.

摘要

乙型肝炎病毒(HBV)是一种高致病性病毒,在全球数百万人中引发慢性肝病。除了有症状的、血清学上明显的感染外,自从引入灵敏度更高的核酸扩增检测法来检测嗜肝DNA病毒基因组及其复制中间体后,隐匿性持续HBV携带状态就已被发现。目前的证据表明,隐匿性HBV感染是急性乙型肝炎痊愈后的常见且长期后果。这种残留感染形式被称为继发性隐匿感染(SOI)。来自土拨鼠HBV感染模型的数据表明,接触少量嗜肝DNA病毒也可导致原发性隐匿感染(POI),即虽可检测到病毒基因组,但检测不到接触病毒的血清学标志物,且肝脏可能未受影响。然而,在这两种形式中,病毒都在淋巴系统中低水平复制。我们简要总结了目前对隐匿性嗜肝DNA病毒持续存在的性质和特征及其已记录和预期的病理后果的理解。

相似文献

1
Persistent occult hepatitis B virus infection: experimental findings and clinical implications.
World J Gastroenterol. 2007 Nov 21;13(43):5682-6. doi: 10.3748/wjg.v13.i43.5682.
2
Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.
J Clin Transl Hepatol. 2015 Sep 28;3(3):211-9. doi: 10.14218/JCTH.2015.00020. Epub 2015 Sep 15.
8
Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.
J Virol. 2004 Feb;78(4):1730-8. doi: 10.1128/jvi.78.4.1730-1738.2004.

引用本文的文献

1
Infections as predictors of NAFLD progression.
Intern Emerg Med. 2022 Nov;17(8):2185-2186. doi: 10.1007/s11739-022-03096-5. Epub 2022 Nov 5.
3
Occult Hepatitis B Virus Infection: An Update.
Viruses. 2022 Jul 8;14(7):1504. doi: 10.3390/v14071504.
7
Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study.
PLoS One. 2016 Nov 11;11(11):e0166317. doi: 10.1371/journal.pone.0166317. eCollection 2016.
10
Genetic variation of occult hepatitis B virus infection.
World J Gastroenterol. 2016 Apr 7;22(13):3531-46. doi: 10.3748/wjg.v22.i13.3531.

本文引用的文献

3
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ann Intern Med. 2007 May 1;146(9):649-56. doi: 10.7326/0003-4819-146-9-200705010-00008.
4
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
Br J Haematol. 2007 Mar;136(5):699-712. doi: 10.1111/j.1365-2141.2006.06465.x.
7
Occult hepatitis B and infliximab-induced HBV reactivation.
Inflamm Bowel Dis. 2007 Apr;13(4):508-9. doi: 10.1002/ibd.20035.
8
Occult hepatitis B virus infection.
J Hepatol. 2007 Jan;46(1):160-70. doi: 10.1016/j.jhep.2006.10.007. Epub 2006 Nov 7.
10
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
Gastroenterology. 2006 Jul;131(1):59-68. doi: 10.1053/j.gastro.2006.04.015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验